deltatrials
Completed PHASE2 NCT00000401

Oral Collagen for Rheumatoid Arthritis

Open Label Multicenter Induction of CII Tolerance in Patients With Rheumatoid Arthritis

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions Rheumatoid Arthritis
Interventions Oral bovine type II collagen
Updated 6 times since 2017 Last updated: May 28, 2013 Started: Jul 31, 1999 Primary completion: Aug 31, 2005 Completion: Aug 31, 2005

Listed as NCT00000401, this PHASE2 trial focuses on Rheumatoid Arthritis and remains completed. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Jul 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • University of Tennessee
Data source: University of Tennessee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Jackson, United States
  • • Memphis, United States